Search Results

absolute benefits patients may expect from adjuvant therapy in their situation. This can be weighed against known long-term adverse effects from receiving adjuvant chemotherapy, optimizing the shared decision-making process between patient and physician

, and whose RT can be limited to the breast and not include the nodes, Dr. Lyons added. She emphasized that shared decision-making is critical in situations such as this. “The patient may want to accept a higher risk of locoregional recurrence versus

-negative NSCLC in a nontrial setting, which can improve the shared decision-making process and better inform treatment recommendations. In this study, 900 patients aged 70 years or older were given AC. Although there are no specific guidelines for the treatment

routinely recommend cytoreductive therapy; however, this is another situation in which shared decision-making is vital. Broadly speaking, the lack of consensus regarding the impact of platelet count in ET suggests this is a complex relationship that is

and performance of cTME after neoadjuvant therapy. When discussing treatment options with an individual patient after local excision, shared decision-making may lead to refraining from cTME. Several factors may contribute to this: first, patient

-making occurs for patients with resectable PDAC and whether specific barriers to the use of NT exist. Further data on patient and physician preferences and the patient experience during NT may highlight opportunities to improve shared decision-making and

expectancy compared with other treatment options in properly selected individuals. The decision by patients to choose AS as the initial management strategy is dependent on individual preferences and plays an important role in shared decision-making. Further

-sensitive malignancies. Thus, reports such as this highlight the potential for immunotherapy to be safely and effectively administered in this unique patient population. A thorough discussion of risks and benefits with the patient and shared decision-making are critical

, a shared decision-making process between physicians and patients was recommended) and because screening practices for this subgroup vary across different Canadian jurisdictions, a sensitivity analysis was conducted, repeating all analyses on women

undergo surveillance unless there is compelling reason not to. However, patients with larger tumors may prefer radiation or chemotherapy if they know they have a higher risk of relapse. So tumor size can facilitate shared decision-making.” The other area